Hedge Fund News | Hedge Week

Hedge funds up 0.62 per cent in November, says BarclayHedge

Hedgeweek Special Reports - Thu, 12/14/2017 - 10:56

Hedge Funds gained 0.62 per cent in November according to the Barclay Hedge Fund Index compiled by BarclayHedge. The index is up 9.08 per cent in 2017, and has had 13 consecutive winning months during which it gained 11.20 per cent return.

“The possibility that the US Senate might pass a tax bill rallied domestic equity markets,” says Sol Waksman (pictured), founder and president of BarclayHedge. “For each of the past 13 months, the monthly close of the S&P 500 has set a new record high.”
 
Once again, the Technology Index powered upward with a 3.63 per cent return in November. Technology has had 12 months of gains in the past 13 months, and is now up 25.29 per cent for the year.
 
The Healthcare and Biotechnology Index bounced back from a 1.57 per cent loss in October with a 2.98 per cent gain in November. Equity Long Bias was up 1.63 per cent, Emerging Markets added 0.64 per cent, Distressed Securities were up 0.59 per cent, and Pacific Rim Equities rose 0.33 per cent.
 
Eight hedge fund indices lost ground in November. The Merger Arbitrage Index was down 0.79 per cent, European Equities gave up 0.57 per cent, Fixed Income Arbitrage lost 0.30 per cent, and Convertible Arbitrage slid 0.21 per cent.
 
All of Barclay’s 17 hedge fund indices are profitable after eleven months. Following the strong performance of the Technology Index, Healthcare & Biotechnology is up 18.70 per cent for the year, Emerging Markets have gained 16.40 per cent, Pacific Rim Equities are up 13.18 per cent, and the Equity Long Bias Index has added 12.67 per cent.
 
The Barclay Fund of Funds Index lost 0.03 per cent in November, but is up 5.66 per cent for the year.

offResults and performanceFundsIndexesFlag: alphaq

Hedge funds up 0.62 per cent in November, says BarclayHedge

Hedgeweek News - Thu, 12/14/2017 - 10:56

Hedge Funds gained 0.62 per cent in November according to the Barclay Hedge Fund Index compiled by BarclayHedge. The index is up 9.08 per cent in 2017, and has had 13 consecutive winning months during which it gained 11.20 per cent return.

“The possibility that the US Senate might pass a tax bill rallied domestic equity markets,” says Sol Waksman (pictured), founder and president of BarclayHedge. “For each of the past 13 months, the monthly close of the S&P 500 has set a new record high.”
 
Once again, the Technology Index powered upward with a 3.63 per cent return in November. Technology has had 12 months of gains in the past 13 months, and is now up 25.29 per cent for the year.
 
The Healthcare and Biotechnology Index bounced back from a 1.57 per cent loss in October with a 2.98 per cent gain in November. Equity Long Bias was up 1.63 per cent, Emerging Markets added 0.64 per cent, Distressed Securities were up 0.59 per cent, and Pacific Rim Equities rose 0.33 per cent.
 
Eight hedge fund indices lost ground in November. The Merger Arbitrage Index was down 0.79 per cent, European Equities gave up 0.57 per cent, Fixed Income Arbitrage lost 0.30 per cent, and Convertible Arbitrage slid 0.21 per cent.
 
All of Barclay’s 17 hedge fund indices are profitable after eleven months. Following the strong performance of the Technology Index, Healthcare & Biotechnology is up 18.70 per cent for the year, Emerging Markets have gained 16.40 per cent, Pacific Rim Equities are up 13.18 per cent, and the Equity Long Bias Index has added 12.67 per cent.
 
The Barclay Fund of Funds Index lost 0.03 per cent in November, but is up 5.66 per cent for the year.

offResults and performanceFundsIndexesFlag: alphaq

Hedge funds up 0.62 per cent in November, says BarclayHedge

Hedgeweek Jobs - Thu, 12/14/2017 - 10:56

Hedge Funds gained 0.62 per cent in November according to the Barclay Hedge Fund Index compiled by BarclayHedge. The index is up 9.08 per cent in 2017, and has had 13 consecutive winning months during which it gained 11.20 per cent return.

“The possibility that the US Senate might pass a tax bill rallied domestic equity markets,” says Sol Waksman (pictured), founder and president of BarclayHedge. “For each of the past 13 months, the monthly close of the S&P 500 has set a new record high.”
 
Once again, the Technology Index powered upward with a 3.63 per cent return in November. Technology has had 12 months of gains in the past 13 months, and is now up 25.29 per cent for the year.
 
The Healthcare and Biotechnology Index bounced back from a 1.57 per cent loss in October with a 2.98 per cent gain in November. Equity Long Bias was up 1.63 per cent, Emerging Markets added 0.64 per cent, Distressed Securities were up 0.59 per cent, and Pacific Rim Equities rose 0.33 per cent.
 
Eight hedge fund indices lost ground in November. The Merger Arbitrage Index was down 0.79 per cent, European Equities gave up 0.57 per cent, Fixed Income Arbitrage lost 0.30 per cent, and Convertible Arbitrage slid 0.21 per cent.
 
All of Barclay’s 17 hedge fund indices are profitable after eleven months. Following the strong performance of the Technology Index, Healthcare & Biotechnology is up 18.70 per cent for the year, Emerging Markets have gained 16.40 per cent, Pacific Rim Equities are up 13.18 per cent, and the Equity Long Bias Index has added 12.67 per cent.
 
The Barclay Fund of Funds Index lost 0.03 per cent in November, but is up 5.66 per cent for the year.

offResults and performanceFundsIndexesFlag: alphaq

Hedge funds up 0.62 per cent in November, says BarclayHedge

Hedgeweek Interviews - Thu, 12/14/2017 - 10:56

Hedge Funds gained 0.62 per cent in November according to the Barclay Hedge Fund Index compiled by BarclayHedge. The index is up 9.08 per cent in 2017, and has had 13 consecutive winning months during which it gained 11.20 per cent return.

“The possibility that the US Senate might pass a tax bill rallied domestic equity markets,” says Sol Waksman (pictured), founder and president of BarclayHedge. “For each of the past 13 months, the monthly close of the S&P 500 has set a new record high.”
 
Once again, the Technology Index powered upward with a 3.63 per cent return in November. Technology has had 12 months of gains in the past 13 months, and is now up 25.29 per cent for the year.
 
The Healthcare and Biotechnology Index bounced back from a 1.57 per cent loss in October with a 2.98 per cent gain in November. Equity Long Bias was up 1.63 per cent, Emerging Markets added 0.64 per cent, Distressed Securities were up 0.59 per cent, and Pacific Rim Equities rose 0.33 per cent.
 
Eight hedge fund indices lost ground in November. The Merger Arbitrage Index was down 0.79 per cent, European Equities gave up 0.57 per cent, Fixed Income Arbitrage lost 0.30 per cent, and Convertible Arbitrage slid 0.21 per cent.
 
All of Barclay’s 17 hedge fund indices are profitable after eleven months. Following the strong performance of the Technology Index, Healthcare & Biotechnology is up 18.70 per cent for the year, Emerging Markets have gained 16.40 per cent, Pacific Rim Equities are up 13.18 per cent, and the Equity Long Bias Index has added 12.67 per cent.
 
The Barclay Fund of Funds Index lost 0.03 per cent in November, but is up 5.66 per cent for the year.

offResults and performanceFundsIndexesFlag: alphaq

Hedge funds up 0.62 per cent in November, says BarclayHedge

Hedgeweek Features - Thu, 12/14/2017 - 10:56

Hedge Funds gained 0.62 per cent in November according to the Barclay Hedge Fund Index compiled by BarclayHedge. The index is up 9.08 per cent in 2017, and has had 13 consecutive winning months during which it gained 11.20 per cent return.

“The possibility that the US Senate might pass a tax bill rallied domestic equity markets,” says Sol Waksman (pictured), founder and president of BarclayHedge. “For each of the past 13 months, the monthly close of the S&P 500 has set a new record high.”
 
Once again, the Technology Index powered upward with a 3.63 per cent return in November. Technology has had 12 months of gains in the past 13 months, and is now up 25.29 per cent for the year.
 
The Healthcare and Biotechnology Index bounced back from a 1.57 per cent loss in October with a 2.98 per cent gain in November. Equity Long Bias was up 1.63 per cent, Emerging Markets added 0.64 per cent, Distressed Securities were up 0.59 per cent, and Pacific Rim Equities rose 0.33 per cent.
 
Eight hedge fund indices lost ground in November. The Merger Arbitrage Index was down 0.79 per cent, European Equities gave up 0.57 per cent, Fixed Income Arbitrage lost 0.30 per cent, and Convertible Arbitrage slid 0.21 per cent.
 
All of Barclay’s 17 hedge fund indices are profitable after eleven months. Following the strong performance of the Technology Index, Healthcare & Biotechnology is up 18.70 per cent for the year, Emerging Markets have gained 16.40 per cent, Pacific Rim Equities are up 13.18 per cent, and the Equity Long Bias Index has added 12.67 per cent.
 
The Barclay Fund of Funds Index lost 0.03 per cent in November, but is up 5.66 per cent for the year.

offResults and performanceFundsIndexesFlag: alphaq

Hedgewire 14/12/17

Hedgeweek Special Reports - Thu, 12/14/2017 - 05:59

Hedgewire 14/12/17

Hedgeweek Special Reports - Thu, 12/14/2017 - 05:59
Syndicate content